MetaCap

Galectin Therapeutics Statistics

NASDAQ: GALTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.69-0.12 (-4.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Galectin Therapeutics by the numbers

Galectin Therapeutics has a market capitalization of $271.4 million based on 100.88M shares outstanding. With trailing EPS of $-0.32, Galectin Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 23.7% below its 50-day average and 16.3% below its 200-day average.

Average daily trading volume is 252.31K shares, or about $678,703 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

GALT valuation vs. peer median

GALT compared with the median of 8 peer companies
MetricGALTPeer medianDifference
Market cap$271.35M$272.21M-0%
Avg. volume252.31K771.61K-67%

Peer median across 8 companies: VCRE, RLMD, FULC, GLSI, EBS, ALT, PRLD, BNTC.

Valuation

Price and trading

Previous close
2.81
Open
2.80
Day range
2.67 – 2.93
52-week range
2.03 – 7.13
52-week change
-49.72%
Beta
—
Volume
257.65K

Dividends and events

Annual dividend
None
Next earnings date
Aug 11, 2025

Additional statistics

Market Cap
271.35M
Forward Pe
-1.60
Eps
-0.32
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.13
Week52 Low
2.03
Avg Volume
252.31K
Shares Outstanding
100.88M
Ma50
3.53
Ma200
3.21
Earnings Date
Aug 11, 2025
Pct From52w High
-62.27%
Pct From52w Low
32.51%

Related